Sumitomo Pharma Co. Ltd. (DNPUF)

PNK: DNPUF · Real-Time Price · USD

5.80

1.70 (41.46%)

At close: May 01, 2025, 9:30 AM

Sumitomo Pharma Income Statement

Financials in JPY. Fiscal year is April - March.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015
Revenue	329.55B	314.56B	330.31B	388.9B	471.35B	555.54B	588.23B	585.59B	588.72B	560.03B	553.26B	548.18B	513.29B	515.95B	520.48B	513.63B	499.11B	482.73B	469.41B	463.71B	460.84B	459.27B	449.59B	452.68B	457.62B	458B	461.42B	445.03B	424.45B	411.64B	404.19B	402.38B	408.58B	403.2B	396.76B	392B	379.74B
Cost of Revenue	131.1B	126.58B	132.34B	146.4B	163.29B	178.92B	179.06B	173.11B	164.71B	157.13B	150.81B	143.93B	140.28B	137.77B	141.13B	144.08B	136.69B	129.67B	121.71B	114.25B	113.59B	113.55B	104.36B	106.19B	109.03B	109.64B	116.2B	111.23B	105.67B	100.08B	99.75B	100.27B	102.06B	104.47B	105.19B	104.84B	103.49B
Gross Profit	198.45B	187.98B	197.96B	242.5B	308.06B	376.63B	409.17B	412.48B	424.01B	402.91B	402.45B	404.25B	373.01B	378.18B	379.35B	369.55B	362.42B	353.06B	347.7B	349.47B	347.25B	345.71B	345.23B	346.49B	348.58B	348.37B	345.23B	333.8B	318.78B	311.57B	304.44B	302.11B	306.53B	298.74B	291.56B	287.16B	276.25B
Operating Income	-117.81B	-166.27B	-176.95B	-134.56B	-143.16B	-76.98B	-15.77B	-16.25B	66.54B	60.23B	41.92B	71.26B	56.26B	71.22B	89.31B	63.94B	66.09B	83.24B	92.51B	95.11B	82.49B	57.88B	79.06B	73.26B	87.31B	91.23B	67.52B	73.6B	57.94B	52.76B	50.08B	46.81B	47.04B	36.93B	31.54B	28.18B	19.02B
Interest Income	53.77B	52.76B	41.59B	41.59B	49.7B	61.27B	67.83B	74.27B	58.05B	25.78B	16.17B	10.12B	7.62B	7.65B	1.37B	6.62B	7.45B	8.23B	8.86B	3.21B	5.54B	8.99B	9.78B	11.26B	9.15B	4.44B	2.9B	1.6B	685M	746M	846M	827M	740M	627M	508M	461M	427M
Pretax Income	-274.86B	-323.11B	-155.3B	-125.08B	-125.58B	-47.92B	19.57B	54.73B	121.61B	82.96B	63.71B	83.46B	63.83B	77.85B	79.25B	63.45B	69.02B	83.95B	96.31B	91.59B	81.32B	65.05B	81.98B	79.2B	91.21B	90.42B	64.14B	78.34B	54.38B	47.22B	47.31B	33.83B	41.67B	39.56B	36.42B	35.13B	33.2B
Net Income	-260.17B	-314.96B	-173.71B	-134.96B	-144.48B	-74.51B	-8.45B	12.68B	82.72B	56.41B	32.32B	55.37B	42.76B	56.22B	67.03B	47.72B	52.31B	40.75B	52.64B	51.09B	40.08B	48.63B	42.83B	29.28B	37.37B	36.54B	33.1B	53.19B	35.03B	28.99B	30.92B	22.41B	27.12B	24.7B	19.8B	16.9B	15.63B
Selling & General & Admin	217.7B	247.24B	275.4B	299.45B	370.92B	373.32B	349.52B	332.32B	264.31B	249.08B	232.38B	220.87B	203.42B	190.37B	203.57B	201.49B	175.47B	154.35B	128.78B	128.45B	158.08B	180.44B	179.47B	184.85B	182.23B	169.13B	181.7B	169.9B	163.81B	172.34B	168.39B	170B	172.5B	174.05B	175.82B	175.51B	175.9B
Research & Development	97.92B	112.64B	129.51B	132.23B	135.28B	131.86B	103.12B	99.18B	96.9B	94.9B	128.79B	129.18B	129.37B	132.68B	103.09B	104.17B	120.8B	115.11B	124.09B	121.19B	101.56B	102.36B	80.99B	83.12B	83.08B	82.14B	86.77B	83.42B	81.41B	80.82B	80.25B	79.58B	81.26B	82.03B	79.06B	78.34B	76.2B
Other Expenses	349M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-126M	-529M	-696M	-814M	-802M	-47M	-545M	-749M	-749M	-2.11B	-1.82B	-1.87B
Operating Expenses	316.26B	354.25B	374.91B	377.06B	451.22B	453.6B	424.94B	428.73B	357.47B	342.67B	360.53B	332.99B	316.75B	306.95B	290.04B	305.6B	296.33B	269.82B	255.19B	254.36B	264.75B	287.83B	266.17B	273.23B	261.27B	257.13B	277.7B	260.19B	260.84B	258.81B	254.35B	255.29B	259.48B	261.8B	260.01B	258.97B	257.23B
Interest Expense	22.24B	21.01B	19.95B	32.11B	32.13B	32.21B	32.49B	3.29B	2.97B	3.05B	2.29B	5.83B	7.96B	8.93B	11.43B	11.78B	9.18B	12.19B	9.73B	5.1B	5.08B	207M	5.61B	5.69B	5.66B	5.71B	420M	454M	581M	631M	687M	773M	852M	919M	939M	941M	938M
Selling & Marketing Expenses	-182.3B	-182.3B	59.86B	59.86B	59.86B	59.86B	37.78B	37.78B	37.78B	37.78B	37.36B	37.36B	37.36B	37.36B	37.74B	37.74B	37.74B	37.74B	37.98B	37.98B	37.98B	37.98B	38.21B	38.21B	38.21B	38.21B	24.08B	24.08B	24.08B	24.08B	26.96B	26.96B	26.96B	26.96B	28.82B	28.82B	28.82B
Cost & Expenses	447.36B	480.83B	507.25B	523.46B	614.51B	632.52B	604B	601.85B	522.17B	499.8B	511.35B	476.93B	457.03B	444.73B	431.16B	449.68B	433.02B	399.49B	376.9B	368.6B	378.35B	401.38B	370.53B	379.42B	370.3B	366.77B	393.9B	371.42B	366.51B	358.88B	354.1B	355.57B	361.54B	366.27B	365.21B	363.82B	360.71B
Income Tax Expense	-14.73B	-8.19B	26.48B	24.13B	38.09B	48.79B	46.78B	59.36B	53.73B	42.36B	49.6B	46.99B	41.76B	41.02B	29.4B	27.53B	24.24B	48.03B	43.67B	40.51B	41.24B	16.42B	39.15B	49.92B	53.84B	53.89B	31.04B	25.15B	19.34B	18.23B	16.39B	11.42B	14.55B	14.86B	16.61B	18.22B	17.56B
Shares Outstanding (Basic)	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M
Shares Outstanding (Diluted)	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.29M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M	397.3M
EPS (Basic)	-654.86	-792.78	-437.24	-339.71	-363.66	-187.55	-21.26	31.92	208.21	142.00	81.36	139.38	107.64	141.51	168.72	120.11	131.66	102.57	132.48	128.59	100.89	122.40	124.66	90.57	110.93	108.82	83.31	133.88	88.18	72.97	77.83	56.39	68.27	62.16	49.83	42.54	39.34
EPS (Diluted)	-654.86	-792.78	-437.24	-339.71	-363.66	-187.55	-21.26	31.92	208.21	142.00	81.36	139.38	107.64	141.51	168.72	120.11	131.66	102.57	132.48	128.59	100.89	122.40	124.66	90.57	110.93	108.82	83.31	133.88	88.18	72.97	77.83	56.39	68.27	62.16	49.83	42.54	39.34
EBITDA	-271.22B	-296.06B	-108.63B	-66.12B	-18.88B	28.29B	80.64B	80.52B	107.87B	98.31B	61.23B	85.6B	65.87B	76.97B	108.08B	81.93B	83.29B	100.29B	112.31B	114.02B	100.62B	75.25B	95.05B	87.29B	104.21B	108.08B	73.01B	87.25B	58.17B	47.85B	47.99B	34.6B	42.52B	34.63B	31.5B	30.22B	19.63B
EBIT	-274.96B	-302.1B	-135.35B	-92.97B	-93.46B	-15.71B	52.06B	58.02B	124.59B	86.01B	59.65B	82.94B	65.44B	80.44B	90.68B	64.92B	67.88B	85.82B	95.72B	98.32B	88.03B	66.88B	89.21B	84.9B	95.71B	107.3B	81.55B	95.79B	73.11B	53.68B	47.99B	34.6B	42.52B	40.48B	37.35B	36.07B	34.13B
Depreciation & Amortization	35.46B	37.77B	37.43B	37.56B	38.96B	41.26B	42.25B	42.61B	41.59B	38.35B	36.24B	31.27B	26.54B	22.67B	19.08B	18.3B	17.52B	17.36B	16.41B	15.52B	14.74B	13.98B	13.96B	10.43B	13.3B	12.89B	5.51B	14.22B	809M	-3.98B	-1.48B	-10.47B	-4.31B	-2.09B	-1.2B	-1.67B	-1.57B